Not applicableEnded earlyNCT05088616What this trial is testingNative American Diabetes ProjectWho this might be right forDiabetesDiabete Type 2Diabetes Mellitus, Type 1+3 more University of Southern California 53
Not applicableStudy completedNCT03602599What this trial is testingChronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy ControlsWho this might be right forGraft Versus Host Disease National Institute of Dental and Craniofacial Research (NIDCR) 190
Not applicableStudy completedNCT01168076What this trial is testingNoninvasive Transcutaneous Glucometer DevelopmentWho this might be right forHealthyPrediabetic State (IGT)Diabetes Mellitus, Type 2+1 more InLight Solutions 500
Testing effectiveness (Phase 2)Study completedNCT00150111What this trial is testingRituximab in the Treatment of Graves' DiseaseWho this might be right forGraves´ DiseaseThyroid Associated Ophthalmopathy Odense University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00001789What this trial is testingBG9588 (Anti-CD40L Antibody) to Treat Lupus NephritisWho this might be right forGlomerulonephritis, MembranoproliferativeLupus Nephritis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Not applicableLooking for participantsNCT06993727What this trial is testingAutoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor TherapyWho this might be right forAutoimmunity Laura ICONARU 500
Not applicableStudy completedNCT04967781What this trial is testingAutoimmunity Contributes to the Severe Progression of COVID-19Who this might be right forCoronavirus Disease 2019 Zhongnan Hospital 162
Testing effectiveness (Phase 2)Looking for participantsNCT04339777What this trial is testingAllogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityWho this might be right forLymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00073281What this trial is testingIslet Transplantation for Patients With Type 1 DiabetesWho this might be right forDiabetes Mellitus, Type 1 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10
Testing effectiveness (Phase 2)Study completedNCT00065260What this trial is testingRabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaWho this might be right forAplastic Anemia National Heart, Lung, and Blood Institute (NHLBI) 54
Not applicableLooking for participantsNCT06591260What this trial is testingRole of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)Who this might be right forMyocarditisVentricular ArrhythmiaInflammatory Cardiomyopathy+6 more Scientific Institute San Raffaele 20
Testing effectiveness (Phase 2)Study completedNCT00195624What this trial is testingAlemtuzumab to Treat Severe Aplastic AnemiaWho this might be right forSevere Aplastic Anemia, RefractorySevere Aplastic Anemia, Relapse National Heart, Lung, and Blood Institute (NHLBI) 47
Not applicableLooking for participantsNCT04421846What this trial is testingStudy of Pathophysiology of Status Epilepticus and Dysimmune EncephalitisWho this might be right forStatus EpilepticusDysimmune Encephalopathy Assistance Publique - Hôpitaux de Paris 400
Early research (Phase 1)Ended earlyNCT00303134What this trial is testingIslet Cell Transplants for DiabetesWho this might be right forDiabetes Mellitus, Type 1 Weill Medical College of Cornell University 3
Not applicableStudy completedNCT01047865What this trial is testingType 1 Diabetes Recurrence in Pancreas TransplantsWho this might be right forDiabetes Mellitus, Type 1 University of Miami 238
Testing effectiveness (Phase 2)Ended earlyNCT01712945What this trial is testingKeratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple SclerosisWho this might be right forMultiple Sclerosis Cambridge University Hospitals NHS Foundation Trust 40
Not applicableStudy completedNCT05315739What this trial is testingVagus Nerve Stimulation for Systemic Lupus ErythematousWho this might be right forSystemic Lupus ErythematosusAutonomic DysfunctionAutonomic Neuropathy+1 more Rigshospitalet, Denmark 75
Testing effectiveness (Phase 2)Study completedNCT04246372What this trial is testingTofacitinib for Immune Skin Conditions in Down SyndromeWho this might be right forDown SyndromeAlopecia AreataAtopic Dermatitis / Eczema+3 more University of Colorado, Denver 47
Not applicableStudy completedNCT00001678What this trial is testingGenetics of Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 39
Not applicableUnknownNCT05635552What this trial is testingAll Eyes on PCS - Analysis of the Retinal Microvasculature in Patients With Post-COVID-19 SyndromeWho this might be right forLong Covid19Post COVID-19 ConditionEndothelial Dysfunction Technical University of Munich 300